From Pictures to Practice Paradigms |
Echocardiography in Hypertrophic CardiomyopathyThe Role of Conventional and Emerging Technologies
Luis C. Afonso, MD, FACC*,
Juan Bernal, MD*,
Jeroen J. Bax, MD ,
Theodore P. Abraham, MD, FACC ,*
* Division of Cardiology, Wayne State University, Detroit, Michigan
Division of Cardiology, University of Leiden, the Netherlands
Division of Cardiology, Johns Hopkins University, Baltimore, Maryland
* Reprint requests and correspondence: Dr. Theodore P. Abraham, Johns Hopkins University, 600 North Wolfe Street, Carnegie 568, Baltimore, Maryland 21287 (Email: tabraha3{at}jhmi.edu).
Hypertrophic cardiomyopathy is a relatively common inherited cardiomyopathy that is occasionally challenging to differentiate from hypertensive heart disease and athlete hearts on the basis of morphologic or functional abnormalities alone. Echocardiography has traditionally played a preeminent role in the diagnosis, formulation of management strategies, and the prognostication of this complex disease. In this review, we briefly profile the utility and pitfalls of established echocardiographic modalities and discuss the evolving role of novel echocardiographic imaging modalities such as tissue Doppler, Doppler-based strain, 2-dimensional strain (speckle tracking imaging), and 3-dimensional imaging in the assessment of hypertrophic cardiomyopathy.
Key Words: hypertrophic cardiomyopathy strain imaging tissue Doppler
|
Abbreviations and Acronyms
| = systolic myocardial strain | | CMR = cardiac magnetic resonance | | HCM = hypertrophic cardiomyopathy | | LA = left atrial | | LV = left ventricular | | LVH = left ventricular hypertrophy | | LVOT = left ventricular outflow tract | | Sa = systolic mitral annular tissue velocity | | SAM = systolic anterior motion | | SR = strain rate | | SRI = tissue Doppler-based strain imaging (SRI) | | TDI = tissue Doppler imaging | | 3D-E = 3 dimensional echocardiography |
|
|